MarketScreener-analyses Merck & Co., Inc. Euronext Paris
Aandelen
MRK
US58933Y1055
MarketScreener-analyses
Merck and Company : Leader in oncology, modest valuation | 29 oktober 2019 om 16:04 uur |
Merck and Company : Leader in oncology, modest valuation | 29 oktober 2019 om 16:04 uur |